{"id":4334,"date":"2023-07-25T14:37:49","date_gmt":"2023-07-25T06:37:49","guid":{"rendered":"https:\/\/regask.com\/?p=4334"},"modified":"2024-10-26T02:49:58","modified_gmt":"2024-10-25T18:49:58","slug":"mfds-%e8%8d%af%e5%93%81%e5%ae%89%e5%85%a8%e6%b3%95%e8%a7%84","status":"publish","type":"post","link":"https:\/\/regask.com\/zh\/mfds-pharmaceutical-safety-regs\/","title":{"rendered":"\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u63d0\u8bae\u90e8\u5206\u4fee\u6539\u836f\u54c1\u76d1\u7ba1\u89c4\u5b9a\u2026"},"content":{"rendered":"<div>\n<div class=\"css-xdofzv\">\n<div id=\"alert__details__read__summary\" class=\"css-25930v\">\n<div class=\"css-xdofzv\">\n<div id=\"alert__details__read__summary\" class=\"css-25930v\">\n<div><a href=\"https:\/\/www.mfds.go.kr\/eng\/index.do\" target=\"_blank\" rel=\"noopener\">\u97e9\u56fd\u98df\u54c1\u836f\u54c1\u5b89\u5168\u90e8 (MFDS)<\/a> \u901a\u8fc7\u5b89\u5168\u901a\u544a\u7b2c2023-333\u53f7\uff0c\u63d0\u8bae\u5bf9\u300a\u836f\u54c1\u5b89\u5168\u6761\u4f8b\u300b\u8fdb\u884c\u90e8\u5206\u4fee\u6539\u3002\u4ee5\u4e0b\u662f\u62df\u8bae\u8349\u6848\u7684\u6458\u8981\uff1a<\/div>\n<div><\/div>\n<ul>\n<li>\u6269\u5927\u539f\u6599\u836f\u6ce8\u518c\u63d0\u4ea4\u6570\u636e\u7684\u8ba4\u53ef\u8303\u56f4\uff08\u7b2c\u5341\u4e94\u6761\u3001\u7b2c\u5341\u516d\u6761\uff09<\/li>\n<li>\u539f\u6599\u836f\u6ce8\u518c\u65f6\u63d0\u4ea4\u7684\u539f\u6599\u836f\u751f\u4ea7\u73b0\u573a\u6570\u636e\u5c06\u6269\u5927\uff0c\u5305\u62ec\u8bc1\u660e\u539f\u6599\u836f\u751f\u4ea7\u548c\u8d28\u91cf\u63a7\u5236\u6807\u51c6\u9002\u5f53\u7684\u6570\u636e\uff0c\u6216\u98df\u54c1\u836f\u54c1\u5b89\u5168\u90e8\u8ba4\u53ef\u7684\u5236\u9020\u8bc1\u4e66\u6216\u540c\u7b49\u8bc1\u4e66\u7684\u6570\u636e\u3002<\/li>\n<li>\u300a\u5883\u5916\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u6279\u51c6\u7a0b\u5e8f\u548c\u65b9\u6cd5\u89c4\u5b9a\u300b\uff08\u7b2c28\uff082\uff09\u6761\uff09<\/li>\n<li>\u7531\u4e8e\u9700\u8981\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u7528\u9014\u7684\u5728\u7814\u65b0\u836f\u8303\u56f4\u5df2\u6269\u5927\u81f3\u5305\u62ec\u5883\u5916\u65b0\u836f\uff0c\u56e0\u6b64\u5df2\u5236\u5b9a\u4e86\u7533\u8bf7\u7a0b\u5e8f\u548c\u63d0\u4ea4\u6587\u4ef6\u7684\u89c4\u5b9a\u3002<\/li>\n<li>\u9664\u65e0\u9700\u83b7\u5f97 GMP \u53d8\u66f4\u6279\u51c6\u7684\u5fae\u5c0f\u53d8\u66f4\u4e4b\u5916\u7684\u5176\u4ed6\u4e8b\u9879\u7684\u89c4\u5b9a\uff08\u7b2c 48.3 \u6761\uff09<\/li>\n<li>\u7531\u4e8e\u5c0f\u53d8\u66f4\u7684\u76ee\u6807\u5f88\u5c11\uff0c\u800c\u53d8\u66f4\u6279\u51c6\u7684\u76ee\u6807\u5f88\u5e7f\u6cdb\uff0c\u56e0\u6b64\uff0c\u53ef\u80fd\u5f71\u54cd\u836f\u54c1\u8d28\u91cf\u7684\u91cd\u5927\u53d8\u66f4\u88ab\u5224\u5b9a\u4e3a\u975e\u5c0f\u53d8\u66f4\uff0c\u9700\u8981\u83b7\u5f97\u53d8\u66f4\u6279\u51c6\u3002<\/li>\n<li>\u300a\u89c6\u529b\u969c\u788d\u8005\u7528\u836f\u54c1\u53ca\u975e\u836f\u54c1\u6807\u7b7e\u65b9\u6cd5\u53ca\u6807\u51c6\u89c4\u5b9a\u300b\uff08\u7b2c 71(2) \u6761\u3001\u7b2c 75(2) \u6761\u3001\u7b2c 75(3) \u6761\uff09<\/li>\n<li>\u76ee\u524d\uff0c\u98df\u54c1\u836f\u54c1\u5b89\u5168\u90e8\u89c4\u5b9a\uff0c\u9488\u5bf9\u89c6\u529b\u3001\u542c\u529b\u969c\u788d\u8005\u4f7f\u7528\u7684\u836f\u54c1\u53ca\u51c6\u836f\u54c1\uff0c\u5fc5\u987b\u6807\u6ce8\u76f2\u6587\u53ca\u89c6\u542c\u8f6c\u6362\u7801\uff0c\u56e0\u6b64\uff0c\u8be5\u6cd5\u89c4\u89c4\u5b9a\u4e86\u6807\u6ce8\u7684\u65b9\u6cd5\u3001\u6807\u51c6\u4ee5\u53ca\u662f\u5426\u6070\u5f53\u7684\u8c03\u67e5\u3001\u8bc4\u4f30\u5185\u5bb9\u548c\u65b9\u6cd5\u3002<\/li>\n<li>\u300a\u836f\u54c1\u8fdd\u6cd5\u9500\u552e\u7f51\u7edc\u76d1\u63a7\u65b9\u6cd5\u548c\u7a0b\u5e8f\u89c4\u5b9a\u300b\uff08\u65b0\u589e\u7b2c71.3\u6761\uff09<\/li>\n<li>\u836f\u54c1\u8fdd\u6cd5\u9500\u552e\u7f51\u7edc\u76d1\u63a7\u59d4\u6258\u4f9d\u636e\u5df2\u7ecf\u786e\u7acb\uff0c\u76d1\u63a7\u65b9\u5f0f\u3001\u6d41\u7a0b\u7b49\u4e5f\u5df2\u7ecf\u51fa\u53f0\u3002<\/li>\n<\/ul>\n<div>\u516c\u4f17\u54a8\u8be2\u5c06\u6301\u7eed\u81f3 2023 \u5e74 9 \u6708 11 \u65e5\u3002<\/div>\n<div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"MuiGrid-root jss1499 MuiGrid-item MuiGrid-grid-md-12\">\n<div class=\"jss1501\">\n<div class=\"jss1521\">\n<div class=\"jss409 jss434 summaryParagraph\">\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<p><a href=\"https:\/\/regask.com\/zh\/%e6%8e%a5%e8%a7%a6\/\">\u8054\u7cfb RegASK \u4e86\u89e3\u6709\u5173\u97e9\u56fd\u6cd5\u89c4\u53d8\u5316\u7684\u66f4\u591a\u4fe1\u606f\u3002\u00a0<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<a href=\"https:\/\/regask.com\/zh\/%e6%8e%a5%e8%a7%a6\/\" class=\"button secondary\" style=\"border-radius:10px;\">\n\t\t<span>\u66f4\u591a\u8be6\u60c5\u8bf7\u8054\u7cfb RegASK<\/span>\n\t<\/a>\n\n<a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/prohibition-wholesaling-under-section-503b-federal-food-drug-and-cosmetic-act\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>\u9605\u8bfb\u66f4\u591a<\/span>\n\t<\/a>\n\n<div class=\"row\"  id=\"row-22043922\">\n\n\t<div id=\"col-1386319963\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<a href=\"https:\/\/regask.com\/zh\/%e6%a1%88%e4%be%8b%e7%a0%94%e7%a9%b6-2\/%e8%b5%84%e6%ba%90-%e6%a1%88%e4%be%8b%e7%a0%94%e7%a9%b6-%e5%88%b6%e8%8d%af-%e7%94%9f%e7%89%a9%e6%8a%80%e6%9c%af\/\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>\u9605\u8bfb\u5236\u836f\u548c\u751f\u7269\u6280\u672f\u884c\u4e1a\u6848\u4f8b\u7814\u7a76<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n<div class=\"MuiGrid-root jss1499 MuiGrid-item MuiGrid-grid-xs-12\">\n<div class=\"jss1500\">\n<div class=\"jss409 jss417 dataText\"><\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u97e9\u56fd\u98df\u54c1\u836f\u54c1\u5b89\u5168\u90e8\uff08MFDS\uff09\u901a\u8fc7\u5b89\u5168\u901a\u544a\u7b2c2023-333\u53f7\u63d0\u8bae\u5bf9\u300a\u836f\u54c1\u5b89\u5168\u6761\u4f8b\u300b\u8fdb\u884c\u90e8\u5206\u4fee\u8ba2\u3002\u4ee5\u4e0b\u662f\u62df\u8bae\u8349\u6848\u7684\u6458\u8981\uff1a\u6269\u5927\u539f\u6599\u836f\u6ce8\u518c\u63d0\u4ea4\u6570\u636e\u7684\u8ba4\u53ef\u8303\u56f4\uff08\u7b2c15\u548c16\u6761\uff09\u539f\u6599\u836f\u6ce8\u518c\u63d0\u4ea4\u7684\u6570\u636e\u2026\u2026<\/p>","protected":false},"author":39,"featured_media":4047,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35,520],"tags":[40],"class_list":["post-4334","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","category-south-korea-regulations","tag-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MFDS: Pharmaceutical Safety Updates | RegASK<\/title>\n<meta name=\"description\" content=\"The MFDS proposes revisions to pharmaceutical safety regulations. Stay informed with RegASK&#039;s expert analysis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/zh\/mfds-\u836f\u54c1\u5b89\u5168\u6cd5\u89c4\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MFDS Proposed Partial Revision of Regulations on the Safety of Pharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"The MFDS proposes revisions to pharmaceutical safety regulations. Stay informed with RegASK&#039;s expert analysis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/zh\/mfds-\u836f\u54c1\u5b89\u5168\u6cd5\u89c4\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-25T06:37:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-25T18:49:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/12\/Amendment-to-the-Clinical-Trials-Regulation-CTR-on-Investigational-Medicinal-Products-IMPs-Labelling.png\" \/>\n\t<meta property=\"og:image:width\" content=\"331\" \/>\n\t<meta property=\"og:image:height\" content=\"301\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/mfds-pharmaceutical-safety-regs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mfds-pharmaceutical-safety-regs\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"MFDS Proposed Partial Revision of Regulations on the Sa&hellip;\",\"datePublished\":\"2023-07-25T06:37:49+00:00\",\"dateModified\":\"2024-10-25T18:49:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mfds-pharmaceutical-safety-regs\\\/\"},\"wordCount\":414,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mfds-pharmaceutical-safety-regs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Amendment-to-the-Clinical-Trials-Regulation-CTR-on-Investigational-Medicinal-Products-IMPs-Labelling.png\",\"keywords\":[\"Latest Insights\"],\"articleSection\":[\"Pharma and Biotech\",\"South Korea\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/mfds-pharmaceutical-safety-regs\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/mfds-pharmaceutical-safety-regs\\\/\",\"name\":\"MFDS: Pharmaceutical Safety Updates | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mfds-pharmaceutical-safety-regs\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mfds-pharmaceutical-safety-regs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Amendment-to-the-Clinical-Trials-Regulation-CTR-on-Investigational-Medicinal-Products-IMPs-Labelling.png\",\"datePublished\":\"2023-07-25T06:37:49+00:00\",\"dateModified\":\"2024-10-25T18:49:58+00:00\",\"description\":\"The MFDS proposes revisions to pharmaceutical safety regulations. Stay informed with RegASK's expert analysis.\",\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/mfds-pharmaceutical-safety-regs\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/regask.com\\\/mfds-pharmaceutical-safety-regs\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Amendment-to-the-Clinical-Trials-Regulation-CTR-on-Investigational-Medicinal-Products-IMPs-Labelling.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Amendment-to-the-Clinical-Trials-Regulation-CTR-on-Investigational-Medicinal-Products-IMPs-Labelling.png\",\"width\":331,\"height\":301,\"caption\":\"Amendment To The Clinical Trials Regulation (ctr) On Investigational Medicinal Products (imps) Labelling\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MFDS\uff1a\u836f\u54c1\u5b89\u5168\u66f4\u65b0 | RegASK","description":"\u98df\u54c1\u836f\u54c1\u5b89\u5168\u90e8\u63d0\u8bae\u4fee\u6539\u836f\u54c1\u5b89\u5168\u6cd5\u89c4\u3002\u8bf7\u5173\u6ce8 RegASK \u7684\u4e13\u5bb6\u5206\u6790\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/zh\/mfds-\u836f\u54c1\u5b89\u5168\u6cd5\u89c4\/","og_locale":"zh_CN","og_type":"article","og_title":"MFDS Proposed Partial Revision of Regulations on the Safety of Pharmaceuticals","og_description":"The MFDS proposes revisions to pharmaceutical safety regulations. Stay informed with RegASK's expert analysis.","og_url":"https:\/\/regask.com\/zh\/mfds-\u836f\u54c1\u5b89\u5168\u6cd5\u89c4\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2023-07-25T06:37:49+00:00","article_modified_time":"2024-10-25T18:49:58+00:00","og_image":[{"width":331,"height":301,"url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/12\/Amendment-to-the-Clinical-Trials-Regulation-CTR-on-Investigational-Medicinal-Products-IMPs-Labelling.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"\u4f5c\u8005":"Benoit Trouwaert","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"2 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/mfds-pharmaceutical-safety-regs\/#article","isPartOf":{"@id":"https:\/\/regask.com\/mfds-pharmaceutical-safety-regs\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"MFDS Proposed Partial Revision of Regulations on the Sa&hellip;","datePublished":"2023-07-25T06:37:49+00:00","dateModified":"2024-10-25T18:49:58+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/mfds-pharmaceutical-safety-regs\/"},"wordCount":414,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/mfds-pharmaceutical-safety-regs\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/12\/Amendment-to-the-Clinical-Trials-Regulation-CTR-on-Investigational-Medicinal-Products-IMPs-Labelling.png","keywords":["Latest Insights"],"articleSection":["Pharma and Biotech","South Korea"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/regask.com\/mfds-pharmaceutical-safety-regs\/","url":"https:\/\/regask.com\/mfds-pharmaceutical-safety-regs\/","name":"MFDS\uff1a\u836f\u54c1\u5b89\u5168\u66f4\u65b0 | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/mfds-pharmaceutical-safety-regs\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/mfds-pharmaceutical-safety-regs\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/12\/Amendment-to-the-Clinical-Trials-Regulation-CTR-on-Investigational-Medicinal-Products-IMPs-Labelling.png","datePublished":"2023-07-25T06:37:49+00:00","dateModified":"2024-10-25T18:49:58+00:00","description":"\u98df\u54c1\u836f\u54c1\u5b89\u5168\u90e8\u63d0\u8bae\u4fee\u6539\u836f\u54c1\u5b89\u5168\u6cd5\u89c4\u3002\u8bf7\u5173\u6ce8 RegASK \u7684\u4e13\u5bb6\u5206\u6790\u3002","inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/mfds-pharmaceutical-safety-regs\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/regask.com\/mfds-pharmaceutical-safety-regs\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/12\/Amendment-to-the-Clinical-Trials-Regulation-CTR-on-Investigational-Medicinal-Products-IMPs-Labelling.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/12\/Amendment-to-the-Clinical-Trials-Regulation-CTR-on-Investigational-Medicinal-Products-IMPs-Labelling.png","width":331,"height":301,"caption":"Amendment To The Clinical Trials Regulation (ctr) On Investigational Medicinal Products (imps) Labelling"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"\u9762\u5411\u9ad8\u6548\u56e2\u961f\u7684\u76d1\u7ba1\u4eba\u5de5\u667a\u80fd\u64cd\u4f5c\u7cfb\u7edf","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"\u4f2f\u52aa\u74e6\u00b7\u7279\u9c81\u74e6\u7279"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts\/4334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/comments?post=4334"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts\/4334\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/media\/4047"}],"wp:attachment":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/media?parent=4334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/categories?post=4334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/tags?post=4334"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}